Advances in Women's Health: Recent Episodes
ReachMD
Advances in Women’s Health addresses advances, breakthroughs and treatments for conditions related to women’s health, as well as preventive measures physicians can advise their patients to pursue. Topics will include breast health as it relates to cancer, ethnicity, fertility and pregnancy; osteoporosis; female athletes’ health and emotional issues; pregnancy and all facets related to it; aging; nutrition and health; eating disorders; alternative medicine; and sex education.
Host: Matt Birnholz, MD
Guest: Jennifer L. Payne, MD
Guest: Melissa Simon, MD
Postpartum depression is a serious medical condition that is among the most common complications during and after pregnancy; however, it is often underdiagnosed.1-4 To learn more about screening patients for postpartum depression, Dr. Matt Birnholz speaks with Dr. Jennifer Payne and Dr. Melissa Simon about screening strategies, the impact of health inequities, and the latest medical guidelines regarding the importance of early screening for postpartum depression.
Dr. Payne is a Professor of Psychiatry and Neurobehavioral Sciences as well as Obstetrics and Gynecology at the University of Virginia, and Dr. Simon is a Professor of Obstetrics and Gynecology at the Northwestern University Feinberg School of Medicine.
References
- American Psychiatric Association. Depressive disorders. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5™. 5th ed. American Psychiatric Publishing; 2013:155-188.
- Bauman BL, Ko JY, Cox S, et al. Vital Signs: Postpartum Depressive Symptoms and Provider Discussions About Perinatal Depression - United States, 2018. MMWR Morb Mortal Wkly Rep. 2020;69(19):575-581.
- Cox EQ, Sowa NA, Meltzer-Brody SE, Gaynes BN. The Perinatal Depression Treatment Cascade: Baby Steps Toward Improving Outcomes. J Clin Psychiatry. 2016;77(9):1189-1200.
- Thompson KS, Fox JE. Post-partum depression: a comprehensive approach to evaluation and treatment. Ment Health Fam Med. 2010;7(4):249-257. …
Guest: Jennifer L. Payne, MD
Guest: Melissa Simon, MD
Since postpartum depression is a serious medical condition that can negatively impact mothers, infants, and partners, it is important to identify symptoms in a timely manner.1-4 Dr. Jennifer Payne and Dr. Melissa Simon are here to share their clinical experiences screening patients for postpartum depression, explore strategies to overcome common challenges in screening, and identify best practices for collaborating in the care of perinatal women.
Dr. Payne is a Professor of Psychiatry and Neurobehavioral Sciences as well as Obstetrics and Gynecology at the University of Virginia, and Dr. Simon is a Professor of Obstetrics and Gynecology at the Northwestern University Feinberg School of Medicine.
References
- American Psychiatric Association. Depressive disorders. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5™. 5th ed. American Psychiatric Publishing; 2013:155-188.
- Campbell SB, Cohn JF, Meyers T. Depression in First-Time Mothers: Mother-Infant Interaction and Depression Chronicity. Dev Psychol. 1995;31:349-357.
- Moore Simas TA, Huang MY, Patton C, et al. The humanistic burden of postpartum depression: a systematic literature review. Curr Med Res Opin. 2019;35(3):383-393.
- Thompson KS, Fox JE. Post-partum depression: a comprehensive approach to evaluation and treatment. Ment Health Fam Med. 2010;7(4):249-257.
Sage Therapeutics and the Sage Therapeutics logo …
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Leigh Anne Cantrell, MD, MSPH
The updated ASCCP guidelines now address the use of dual-stain technology for cervical cancer management. CINtec PLUS Cytology is a test for the co-expression of p16 and Ki67 and confirms the presence of a transforming HPV infection and defines patients with high-risk cervical disease. To learn more about these guidelines and how to apply them in practice, join Dr. Leigh Cantrell, Medical Physician and Fellow in the American College of Obstetrics and Gynecology.
COBAS and CINTEC are trademarks of Roche.
All other product names and trademarks are the property of their respective owners. 07/24
Host: Matt Birnholz, MD
Guest: Kay Matthews, LCHW
Ms. Kay Matthews has lived experience with postpartum depression and now advocates for others as the Executive Director and Founder of Shades of Blue, which is dedicated to breaking cultural barriers in maternal mental health. Tune in to hear her speak with Dr. Matt Birnholz about her journey with postpartum depression, barriers that can prevent or delay patients from seeking care, and strategies for combatting stigma and ensuring a timely diagnosis.
Sage Therapeutics and the Sage Therapeutics logo are registered trademarks of Sage Therapeutics, Inc.
Sage Therapeutics, Inc. All rights reserved.
Sage Therapeutics ©2024 MRC-PPD-00792 06/2024
Host: Blake Zwerling, MD
The Society of Family Planning and the Society of Maternal Fetal Medicine have released updated guidelines for medication abortion. Tune in as Dr. Blake Zwerling, Assistant Clinical Professor of Complex Family Planning, reviews these updates and shares how they can be used in clinical practice.
Guest: Christena Raines, NP
Perinatal mood disorders are among the most common complications during pregnancy and immediately following delivery. So front line providers need to be able to initiate treatment. Perinatal Psychiatric Nurse Practitioner and Adjunct Professor of Psychiatry at UNC Chapel Hill, Christena Raines, discusses her session at the 26th Annual Nurse Practitioners in Women’s Healthcare Conference and the importance of recognizing and treating perinatal mood disorders in our female patients.
Guest: Dawn Kimberly Hopkins, PhD, WHNP-BC
Understanding the manifestations of polycystic ovary syndrome (PCOS) can help to identify this condition in women better. And though it’s a common condition, some providers are unaware of how to diagnose it. Dig into the pathophysiology of PCOS with Dr. Dawn Kimberly Hopkins, Research Associate at the Henry Jackson Foundation in Bethesda, Maryland.
Guest: Genevieve Hofmann, NP
Menopause can impact everyday life, and many women go untreated for their menopausal symptoms. To learn more about some of the complex issues surrounding menopause management, join Dr. Genevieve Hofmann, Women’s Health Nurse Practitioner, Certified Menopause Clinician, and Assistant Professor of OB/GYN Health at the University of Colorado School of Medicine, who will be discussing these strategies at the 2023 Annual NPWH Women’s Healthcare Conference.
Guest: Jennifer Herrmeyer, RN
Approximately less than 30 percent of domestic violence patients will seek care for their injuries, so it’s important for us to reach out to those in need. How can we be better at identifying and caring for these patients? Tune in to learn more with Ms. Jennifer Herrmeyer, Emergency Department Nurse at Hennepin Healthcare in Minneapolis, Minnesota.
Guest: Sadia Haider, MD, PhD
After a historic year of legislation for abortion and contraception, there are still many questions surrounding patient care. Tune in as Dr. Sadia Haider, Interim Chair of OB-GYN at RUSH University and President Elect of the Society of Family Planning, discusses the research presented at the 2023 Society of Family Planning Annual Meeting.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Emily M. Godfrey, MD, MPH
A recent study presented at the 2023 ACOG Annual Clinical and Scientific Meeting examined patient perspectives on clinician communication regarding medication abortion during telemedicine versus in-clinic visits and found that patients prefer to receive abortion care via telemedicine. Learn more about the study’s design and results with Dr. Charles Turck and Dr. Emily Godfrey, Professor of Family Medicine and Obstetrics and Gynecology at the University of Washington.
Guest: Mitchell D. Creinin, MD
Dive into the research presented at the 2023 ACOG Annual Scientific and Clinical Meeting that found that the use of levonorgestrel 52-mg intrauterine device (IUD) in patients with heavy menstrual bleeding reduced blood loss by more than 90 percent over six months with Dr. Mitch Creinin, Professor in the Department of Obstetrics and Gynecology as well as the Director of the Complex Family Planning Fellowship at the University of California Davis Health.
Guest: Mitchell D. Creinin, MD
While the use of levonorgestrel 52-mg intrauterine device (IUD) has been shown to reduce blood loss in patients with heavy menstrual bleeding, these same patients are at an increased likelihood of expelling the IUD. That’s why it’s important to set realistic expectations with patients, as Dr. Mitch Creinin from the University of California Davis Health explains.
Guest: Tiffany A. Moore Simas, MD, MPH, MEd, FACOG
According to a poster that was featured at the 2023 ACOG Annual Clinical and Scientific Meeting, only 75 percent of patients at UMass Chan Medical School were screened for perinatal mental health conditions, and of those screened, white patients were more likely to be connected with appropriate care and treatment than black or Hispanic patients. Dive deeper into the findings that underscore the importance of addressing disparities and inequities in perinatal depression care with Dr. Tiffany Moore Simas, Chair of the Department of Obstetrics and Gynecology at UMass Chan Medical School.
Guest: Tiffany A. Moore Simas, MD, MPH, MEd, FACOG
Host: Charles Turck, PharmD, BCPS, BCCCP
New guidelines regarding the screening, diagnosis, and pharmacological treatment of perinatal mental health conditions as well as resources like in-depth toolkits and implementation guides are now available to help optimize the management of patients with perinatal mental health conditions. Find out how these tools can help you better address one of the most common complications of pregnancy with Dr. Charles Turck and Dr. Tiffany Moore Simas, the Chair of the Department of Obstetrics and Gynecology at UMass Chan Medical School who presented a few sessions focusing on this exact topic at the 2023 ACOG Annual Clinical and Scientific Meeting.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Roberto Romero, MD, DMedSci
Renowned international expert Dr. Roberto Romero joins Dr. Lee Shulman to walk us through maternal anti-fetal rejection. Find out about its pathophysiology, mechanisms of disease, approach to diagnosis, and potential treatment so that you can broaden your understanding and improve the care you provide.
Host: Jennifer Caudle, DO
Guest: Tamera A. Paczos, MD, FACOG, FACP
The utility of p16 and Ki-67 immunostaining in biopsies has helped lead to the development of dual staining in cytology specimens. So what do clinicians need to know about the dual stain cytology test? Take a deep dive into this topic as Dr. Jennifer Caudle is joined by Dr. Tamera A. Paczos, Vice President, Associate Chief Medical Officer with BioReference Laboratories.
COBAS and CINTEC are trademarks of Roche.
All other product names and trademarks are the property of their respective owners. 02/23
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Alexandra Benachi, MD, PhD
Guest: Julien Zuber, MD, PhD
Program Chairman:
Roberto Romero, MD, DMedSci
Chief, Perinatology Research Branch
Division of Maternal-Fetal Medicine and Obstetrics
Division of Intramural Research
NICHD/NIH/DHHS
Editor-in-Chief for Obstetrics
The American Journal of Obstetrics and Gynecology
There exists a long-standing controversy about drawing parallels between transplant and pregnancy immunology. Listen in as Drs. Alexandra Benachi, Julien Zuber, and Lee Shulman discuss why these considerations are so important for you and your colleagues, patients, and their families to understand. Discover how links between kidney transplantation and maternal anti-fetal rejection may impact your practice and spark new pathways in medicine.
Host: Jennifer Caudle, DO
Guest: Diane M. Harper, MD, MPH, MS
There are several testing methods available for cervical cancer screening, such as co-testing and primary HPV testing. So what are some of the most prominent benefits and limitations of these and other testing approaches? Joining Dr. Jennifer Caudle to break down the latest advancements in cervical cancer screening is Dr. Diane Harper, a Professor in the Departments of Family Medicine and Obstetrics and Gynecology at the University of Michigan.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Masja de Haas, MD, PhD
Program Chairman:
Roberto Romero, MD, DMedSci
Chief, Perinatology Research Branch
Division of Maternal-Fetal Medicine and Obstetrics
Division of Intramural Research
NICHD/NIH/DHHS
Editor-in-Chief for Obstetrics
The American Journal of Obstetrics and Gynecology
Neonatal alloimmune neutropenia (NAIN or NIN) is a neutrophil blood group antagonism similar to HDFN and FNAIT. Its presentation varies clinically and ranges from asymptomatic to severe manifestations such as sepsis and meningitis. Listen in as Drs. Masja de Haas and Lee Shulman discuss clinical clues that should catch your eye. Discover novel yet simple ways to be vigilant and make the right clinical calls.
HPV testing plays an important role in cervical cancer screening, but not every patient whose HPV-positive will develop cervical cancer. One option that can help us identify which HPV-positive patients are truly at risk is CINtec PLUS Cytology, an immunohistochemistry test that simultaneously detects p16 and Ki67 biomarker proteins. Learn more about how this dual staining technique works in this video.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: James B. Bussel, MD
Program Chairman:
As the platelet equivalent of hemolytic disease of the fetus and newborn, fetal and neonatal alloimmune thrombocytopenia (FNAIT) is an uncommon yet complex and life-threatening bleeding disorder that results from incompatibility between mother and baby for platelet-specific antigens. Despite relatively normal platelet function, in the setting of severe thrombocytopenia, intracranial hemorrhage is a consequence. Drs. Shulman and Bussel discuss advances in management strategies and concrete steps you can take to lower the risk and stop the progression of this disorder in your patients.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Linda Bradley, MD
Join Drs. Linda Bradley and Lee Shulman as they discuss factors contributing to disparities in care for patients with endometriosis and/or uterine fibroids. They offer practical tips to overcome the disproportionate disease burden that especially impacts women of color. Cut through the noise to clearly hear each patient’s voice. Your clinical impact may be profound.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Kenneth J. Moise Jr., MD
Program Chairman:
Are you taking the right steps to consistently ensure all of your patients at risk of alloimmune disorders of pregnancy, specifically HDFN, receive a helping hand plus timely and appropriate clinical care? Despite having considerable clinical consequences, this area of medicine is not fully understood by many clinicians. Drs. Shulman and Moise provide expert insight on red blood cell alloimmunization, highlighting essential pathophysiology and current and evolving management strategies. Join us to learn new ways to approach this complicated and rare clinical condition.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Kenneth J. Moise Jr., MD
Program Chairman:
Are you taking the right steps to consistently ensure all of your patients at risk of alloimmune disorders of pregnancy, specifically HDFN, receive a helping hand plus timely and appropriate clinical care? Despite having considerable clinical consequences, this area of medicine is not fully understood by many clinicians. Drs. Shulman and Moise provide expert insight on red blood cell alloimmunization, highlighting essential pathophysiology and current and evolving management strategies. Join us to learn new ways to approach this complicated and rare clinical condition.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Nanette F. Santoro, MD
Tune out the noise and get to the heart of managing menopause and associated vasomotor symptoms. This program provides highlights from the 2022 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting. Join Drs. Nanette Santoro and Lee Shulman as they dive into the latest research, which could alter your current practice patterns and help your patients cool off.
Host: Ayman Al-Hendy, MD
Despite its profound impact, endometriosis remains critically undermanaged. This program provides highlights from a live symposium at the annual meeting for obstetrics and gynecology professionals and is based on patient & provider surveys. Join Dr. Ayman Al-Hendy to explore management gaps, the role of GnRH antagonists in addressing deficits, and the latest research, which he presented with Drs. Andrea Lukes and Lee Shulman—you might just alter your current practice patterns.
Host: Jeffery D. Dunn, PharmD, MBA
Guest: Gary M. Owens, MD
Guest: Anita L. Nelson, MD
Are you ready to see what is on the horizon to more effectively navigate vasomotor symptoms (VMS)? Join Drs. Dunn, Owens, and Nelson as they discuss highlights from a symposium held at AMCP 2022 featuring the latest data on the impact of menopause and evolving treatments options. They provide guidance, context, and recommendations for the medical management of VMS beyond estrogen. The nonhormonal treatment options that are currently being studied represent a new horizon for both patients and payers.
Host: Patty Cason, RN, MS, FNP-BC
Guest: Joely Pritzker, RN, MS, FNP-C
Are you ready to apply the latest counseling techniques to address the contraceptive revolution?
Join nurse practitioners Patty Cason and Joely Pritzker as they briefly review the history of contraceptive counseling and then use case vignettes to illustrate how shared decision-making techniques will support the appropriate use of nonhormonal contraceptive options, such as the vaginal pH modulator (VPM).
Participating in this activity will ensure that you are ready to effectively counsel patients on their many options so that each patient’s reproductive and sexual health goals can be met.
Host: David J. Portman, MD
Guest: Patty Cason, RN, MS, FNP-BC
Guest: David L. Eisenberg, MD, MPH, FACOG
Are you ready for the contraceptive revolution? Are you applying the latest information on contraceptive efficacy, recent clinical trial data, and sexual satisfaction when counseling your patients on contraceptive options? Join Dr. David Portman, Dr. David Eisenberg, and Ms. Patty Cason as they discuss the novel mechanisms of action of cutting-edge, non-hormonal contraceptive options, such as the vaginal pH modulator (VPM). Participating in this activity will ensure that you are prepared to discuss sexual and reproductive goals with your patients and confirm that your patients’ goals are being met.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Ayman Al-Hendy, MD
Surgery has long been the default choice when managing uterine fibroids and endometriosis. However, over the past few years, reliable and durable medical interventions have emerged, notably GnRH antagonist therapy. Clinical trial data for GnRH antagonists highlight both their safety and efficacy for a broad demographic of patients. Join Drs. Lee Shulman and Ayman Al-Hendy as they discuss the “how” and the “why” of a paradigm shift that is occurring, changing our focus from surgery to first-line medical intervention for uterine fibroids and endometriosis.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Andrea S. Lukes, MD, MHSc, FACOG
By 50 years of age, 70% to 80% of women are affected by uterine fibroids, and nearly 10% of women are affected by endometriosis. Clinical trial data demonstrate that GnRH antagonist therapy can dramatically impact pain and bleeding and improve results across all EHP-30 domains. Join Drs. Lee Shulman and Andrea Lukes as they dive into these data and offer strategies to help you better incorporate patient-centric medical management for uterine fibroids and endometriosis into your clinical practice.
Guest: Peter Goadsby, MD, PhD, DSc
Guest: Kathleen B. Mullin, MD
Women with migraine have unique needs that often remain undermanaged. Have you taken a critical look at the standard of care and how current treatment strategies have recently shifted? Groundbreaking research on the calcitonin gene-related peptide (CGRP) pathway has led to the development of new medications that act on the specific cascade of inflammatory response associated with migraine. Also called gepants, the CGRP receptor antagonists confer clinical benefit to patients who seek better control of their migraines.
Tune in to this Women’s Health 2021 program to hear our experts, Drs. Peter Goadsby and Kathleen Mullin, discuss the diagnosis of migraine with a focus on the recent evolution of acute and preventive treatment strategies and the role of gepants. Are you doing all you can to ensure that your patients’ needs are optimally addressed?
Host: Anita L. Nelson, MD
How confident are you in determining which of your patients with endometriosis are suitable candidates for medical intervention? Do you ask about each patient’s goals and preferences? Have you heard about the paradigm shift occurring in the medical management of endometriosis?
While medical management of endometriosis is often a secondary consideration to surgery, it should often be the first line of treatment. Join Dr. Anita Nelson as she discusses long-standing and novel medical strategies for managing endometriosis. Find out how you can use shared decision-making strategies to help you provide more options to your patients. Join us and take an important first step that can improve outcomes and quality of life for your patients while enabling them to make educated decisions about their immediate and long-term treatment.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Erica E. Marsh MD, MSCI, FACOG
Hear from Dr. Erica Marsh and Dr. Lee Shulman as they discuss the burden, prevalence, and treatment of uterine fibroids and endometriosis and the disproportionate impact these conditions have on vulnerable populations. Learn how to prioritize early diagnosis and treatment to improve outcomes for your patients; as well as evaluating barriers to proper diagnosis and treatment
Our experts offer strategies to guide discussions beyond surgical treatment approaches to include pharmacotherapeutic options such as GnRH agonists and new oral GnRH antagonists. Open communication with patients allows them to carefully consider symptom severity, risks, and fertility preferences to optimize treatment outcomes and patient satisfaction. Tune in to make sure that you’re really doing all you can for your patients.
Host: Anita L. Nelson, MD
In this Women’s Health 2021 lecture, Dr. Anita Nelson discusses why uterine fibroids are such a high priority for both women and their clinicians. Listen in as she shares strategies to engage patients in discussions about their fibroid symptoms and their preferences for treatment. Dr. Nelson also evaluates the latest evidence on the mechanisms of action, safety, and efficacy of the newer class of therapies that are now available and can improve the quality of life for women with fibroids.
Host: Anita H. Clayton, MD
Listen in as Dr. Anita Clayton takes us through the importance of screening for postpartum depression (PPD) and reaching an early diagnosis in the perinatal and postnatal stages of pregnancy. This Women’s Health 2021 lecture also covers the exciting new agents that are targeted specifically for PPD. Find out how they compare to the traditional antidepressants and how they can improve the quality of life for your patients with PPD.
Host: Andrea Singer, MD, FACP, CCD
Guest: Paul A. Anderson, MD
Guest: Susan V. Bukata, MD, FAOA, FAAOS
While there’s growing awareness among orthopedic surgeons that osteoporosis is the underlying cause of fractures, there is often a disconnect between this recognition and action in the form of treatment to prevent subsequent fractures. In this discussion, Drs. Andrea Singer, Paul Anderson, and Susan Bukata address the pathophysiology of osteoporosis and the need to identify patients at risk for additional fractures. Osteoporosis treatment (including pharmacotherapy) can play a critical role in preventing future fractures, but physicians must first recognize that fracture is a sentinel event and treat it as a call to action.
Host: David L. Eisenberg, MD, MPH, FACOG
Many women prefer to use a nonhormonal contraceptive. They also want the freedom to self-administer on demand and want assurances that the contraceptive is safe, effective, and has received FDA approval. One such contraceptive is a self-administered, hormone-free gel that functions as a vaginal pH modulator. Join Dr. David Eisenberg as he describes the evolution of this vaginal pH modulator and the clinical trials leading to FDA approval. Even more significant is patient acceptance, which was remarkably high for this contraceptive. In fact, approximately 9 out of 10 women participating in the clinical trials indicated they would continue using the vaginal pH modulator and also recommend this novel method to their friends.
Host: Brooke M. Faught, DNP, WHNP-BC,NCMP, IF
Our patients express a number of misperceptions about combined hormonal non-LARC contraceptives such as the contraceptive patch, vaginal rings, and oral contraceptive pills. How well do you explain the advantages and disadvantages of these different options to your patients? How often have you prescribed what appeared to be a good contraceptive method for your patients only to have them be dissatisfied and become nonadherent?
Join Dr. Brooke Faught in this Women’s Health 2021 lecture as she tackles these issues and offers insights into how to discuss the full range of combined hormonal non-LARC contraceptive options with your patients using shared decision-making strategies. Remember, each patient’s needs, goals, and cultural background are important factors in a patient-centric approach to the choice of contraception.
Guest: Gregory Pokrywka MD, FACP, FNLA, FASPC, NCMP
Guest: Karol Watson, MD, PhD
Join us to discover optimal ways to identify women at risk or with atherosclerotic cardiovascular disease (ASCVD). In this Women’s Health 2021 lecture, our experts, Dr. Gregory Pokrywka and Dr. Karol Watson, dive deeper into evidence-based approaches to assess and manage ASCVD in women. They discuss topics from lifestyle modifications to recent clinical trial data on the use of omega-3 fatty acids for ASCVD event reduction.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Michelle Y. Owens, MD
OB-GYN clinicians can improve how they communicate with their patients about hemolytic disease of the fetus and newborn or HDFN. Strategies include encouraging patients to talk about their feelings when learning about this condition and communicating with them in terms that are not overly complex. In this program, Drs. Lee Shulman and Michelle Owens discuss how to break things down for the patient in front of you and explain how to use a read-back approach. This tactic ensures that your patient has absorbed what was discussed and also allows you to identify gaps in her understanding that can be addressed with further counseling.
Host: Hector O. Chapa, MD, FACOG
Guest: Susan Crowe, MD
Both UNICEF and WHO recommend exclusive breastfeeding for the first six months of life, starting within the very first hour of birth. But are we adhering to that recommendation? Joining Dr. Hector Chapa to discuss the importance of breastfeeding shortly after delivery and how we can help our patients and their newborns reap the benefits of this golden hour is Dr. Susan Crowe, Director of Outpatient Breastfeeding Medicine Consultative Services at Stanford Children's Health who recently spoke about this topic at the 2021 ACOG Annual Clinical and Scientific Meeting.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Kenneth J. Moise, Jr., MD
Guest: Christopher Robinson, MD
Hemolytic disease of the fetus and newborn (HDFN) is a rare disease that occurs due to the incompatibility between fetal and maternal red cell antigens. HDFN can lead to both short- and long-term consequences, including potentially fatal outcomes. In order to better prevent these associated issues, the timely evaluation, recognition, and treatment of HDFN are critical.
Listen in as three leading experts, Drs. Lee Shulman, Kenneth Moise, and Christopher Robinson, join together to discuss new epidemiologic evidence, the underlying pathophysiology of HDFN, health equity, and evolving management strategies you can implement to improve your clinical practice.
Host: Ana Maria Rosario
Guest: Patricia M. Boatwright, MD
As any healthcare professional would agree, being passionate about your practice is key to having a good relationship with your patients. But choosing a specific specialty isn’t always an easy or clear decision. Joining Ana Maria Rosario to share how she came to her decision and a few experiences that made her into the healthcare professional she is today is Dr. Patricia Boatwright, an ob-gyn and Associate Professor of Surgery and Population Health Sciences at Duke University School of Medicine.
Guest: Patricia M. Boatwright, MD
Ob-gyn Dr. Patricia Boatwright once cared for a patient who told her the following philosophy: "If it doesn't bother you, don't bother it." Sadly, this is far from the only isolated event in which healthcare professionals hear this or a similar mantra from their patients. To help us better manage this all-too-common occurrence, Dr. Boatwright walks us through this particular patient case and how she encourages her patients to listen to their bodies rather than their peers.
Host: Lee P. Shulman, MD, FACMG, FACOG
Guest: Anna-Barbara Moscicki, MD
Updated cervical cancer screening guidelines were published by both the American Society for Colposcopy and Cervical Pathology (ASCCP) and the American Cancer Society (ACS). Dr. Lee Shulman leads a discussion with Dr. Anna-Barbara Moscicki on the recent guidelines, the range of cervical cancer screening tests, and the impact on risk stratification and patient management.
Host: Ana Maria Rosario
Guest: Patricia M. Boatwright, MD
When a patient comes to an appointment saying, “I want” or “I need,” it can be difficult to challenge them. But as ob-gyn Dr. Patricia Boatwright explains, doing so is absolutely critical to ensuring they receive the best and most appropriate care. Tune in to hear Ana Maria Rosario and Dr. Boatwright discuss a patient case and how we can do right by our patients, even if it means challenging their—or even a colleague's—opinion.
Host: Linda Bradley, MD
In this activity, Dr. Linda Bradley reviews risk factors for uterine fibroids, the use of TVS,
Host: Nanette F. Santoro, MD
In this activity, Dr. Nanette F. Santoro explains risk factors for vasomotor symptoms, reviews current medical options for this bothersome problem, and describes the mechanism of action of a new class of nonhormonal agents: selective neurokinin-3 receptor antagonists.
Host: Floor J. Backes, MD
Guest: Robert L. Coleman, MD, FACOG, FACS
Does immunotherapy play a role in improving quality of life and survival for patients with ovarian cancer? Learn how experts are determining immunotherapy’s place in the treatment plan during the PARP era and what’s on the horizon.
Host: Paul Doghramji, MD
Guest: Megan Arnot
Menopause is an inevitable transition in every woman’s life, but what if engaging in a basic physiological need like sex could delay its onset? Researching this potential connection is Megan Arnot, a Ph.D. candidate in the Department of Anthropology at the University College London. As the lead author of the study, she walks us through her findings and the range of factors they investigated, like the type of sexual activity and whether or not women lived with a partner.
Host: Jenn Simmons, MD
Guest: Susan Domchek, MD
Anytime the topic of genetic testing comes up in the context of breast and ovarian cancers, one question that undoubtedly arises is: who exactly should be tested? That’s the FAQ Dr. Susan Domchek, Director of the McDonald Women’s Cancer Risk Evaluation Center at the Hospital of the University of Pennsylvania, answers.
Host: Mario R. Nacinovich, Jr., MSc
Guest: Kara Rood, MD
A recent study following 346 pregnant patients found that 63 percent of the women were admitted into the hospital for uncertain diagnosis or delivery—all because preeclampsia has many of the same symptoms of other diseases. The good news, however, is that there’s a new test currently underway that could make the diagnosis and treatment of preeclampsia easier in order to prevent potentially dangerous outcomes for the mother and baby, as OB/GYN Dr. Kara Rood explains.
Guest: David J. Portman, MD
Providing the best care to your patients goes hand in hand with being aware of all the updates surrounding sexual health disorders, but unfortunately, this is often easier said than done. To help you make the most out of your limited time with patients, Founder and Director Emeritus of the Columbus Center for Women’s Health Research Dr. David Portman shares tips on how you can stay current on sexual health topics.
Host: Patrice L Basanta-Henry, MD, MHSc, FACOG
Egg freezing, or oocyte cryopreservation, can be a major relief for women who wish to preserve their fertility, allowing patients to wait for the “right time.” What are the latest advances in technology and protocol for this procedure, and who are the right patients? Host Dr. Patrice Basanta Henry welcomes guest expert Dr Kenan Omurtag to address these and other questions. Dr. Omurtag is Assistant Professor of the Division of Reproductive Endocrinology and Infertility at Washington University School of Medicine in St Louis, Missouri.
Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Host Dr. Renee Allen welcomes Dr. Victoria Green, renowned breast cancer researcher and OB/GYN clinician. Dr. Green is an Associate Professor in the Department of Gynecology & Obstetrics at Emory University School of Medicine. She will review USPSTF recommendations of biennial mammograms compared to ACOG's recommendations, as well as differences in how we define 'breast awareness' versus breast self-examination. Join the discussion!
Host: Jennifer Caudle, DO
Guest: Renée Simone Yolanda Allen, MD, MHSc., FACOG
Host Dr. Jennifer Caudle welcomes Dr. Renee S. Allen, Board certified OB/GYN and hospitalist, Fellow of ACOG, and Masters of Health Sciences from Atlanta, Georgia. Dr. Allen shares her expertise as an OB/GYN hospitalist, the growing support from ACOG in this new arena, and the goals of an emerging subspecialty.
Host: Matt Birnholz, MD
Studies in the field of anthropology have shown that having a healthy grandmother plays a critically positive role in family cohesion. But the wholistic, personalized health needs of women in their elder years are not always recognized. This care disparity is all the more prominent in general OB/GYN practice, but thanks to the work of a select few, the trends may be about to change.
Dr. Matt Birnholz speaks with Dr. Sarah Berga, Professor and Chair of OB/GYN at Wake Forest School of Medicine at ACOG’s annual meeting in San Francisco. They discuss maintaining grandmothers' health across both physiological and psychological spectra, and how this attention in care fundamentally changes larger family units for the better.
Host: Michael Krychman, MD
For women in their 40's and 50's, approximately one in four will develop a pelvic floor disorder such as urinary incontinence. By the age of 80, that prevalence rises to more than 50 percent. The struggle with a pelvic floor disorder has lasting effects on a woman's sexual health, leading to numerous psychosocial and physical consequences in turn. But of equal concern to many patients dealing with the symptoms of their disorder is the potential aftermath of reconstructive surgical treatments, such as mesh slings, due to their troubling complication rates. Are these concerns justified, and if so, how can the risks be mitigated by both physicians and patients?
Joining Dr. Michael Krychman to discuss the misconceptions versus realities of pelvic floor disorder treatments is Dr. Cheryl Iglesia, Professor in the departments of OB/GYN and Urology at the Georgetown University School of Medicine, and Drector of the Female Pelvic Medicine and Reconstructive Surgery section of Medstar Washington Hospital Center in Washington, DC.
Host: Michael Krychman, MD
Many clinicians think that one of the most dangerous things a woman will ever do in her life is to carry and conceive a child. Stemming from this belief, several misconceptions have risen within the medical community, and by extension the general public, concerning risks of sexual activity during pregnancy. Joining host Dr. Michael Krychman at ACOG's annual scientific meeting to clarify the facts versus myths on sexuality during and after this important life event is Dr. Haywood Brown, Professor and Chair of the Department of Obstetrics and Gynecology at Duke University Medical Center.
Host: Maureen Whelihan, MD
The increasingly recognized concept of a clinician's "work-life balance" is critical to thriving and avoiding burnout, but the philosophy behind this balance remains poorly understood. Some argue that adequate time alottment to one's priorities is the key factor in sustaining a positive medical career trajectory, but a select few believe that time allocation alone is not enough. Dr. Michael Foley, Chairman of the Department of Obstetrics and Gynecology at Banner University Medical Center-Phoenix, argues in favor of what he calls work-life harmony, where aspects of meaningfulness, relationships, and wellbeing better guide one's life and career decisions. Joining host Dr. Maureen Whelihan at ACOG's Annual Scientific Meeting in San Francisco, Dr. Foley applies a martial arts-centered perspective on medical careers based on his extensive experience as a seventh-degree black belt and the founder of The Center for Humane Living.
Host: Matt Birnholz, MD
Dr. Matt Birnholz welcomes Dr. Tom Gellhaus, President-Elect of The American College of Obstetricians and Gynecologists, to discuss his vision for ACOG's initiatives to come, inspired in part by both his unique clinical training background and his extensive legislative activity experience on behalf of OB/GYN specialists nationwide.
Dr Gellhaus is Clinical Associate Professor of OB/GYN and Director of General OB/GYN at the University of Iowa Hospitals and Clinics in Iowa. City.
Host: Matt Birnholz, MD
Dr. Matt Birnholz welcomes Dr. Jeanne Conry, 64th President of The American Congress of Obstetricians and Gynecologists,
Host: Matt Birnholz, MD
Dr. Matt Birnholz welcomes Dr. Mark DeFrancesco, 66th President of The American College of Obstetricians and Gynecologists, to the program. Dr. DeFrancesco looks back at the accomplishments of his immediate predecessors, and reflects on the three-fold initiative to which he will dedicate his efforts on behalf of ACOG to advance the OB/GYN specialty for years to come.
Dr. DeFrancesco is managing partner at Westwood Women’s Health in Waterbury, Connecticut, a division of Women’s Health Connecticut. He is a founding member of this organization, and served as its chief medical officer for many years.
Host: Matt Birnholz, MD
Dr. Matt Birnholz welcomes Dr. Hal Lawrence, Executive Vice President and CEO of the American College of Obstetricians and Gynecologists, to the program. Dr. Lawrence describes the clinical and administrative experiences that helped prepare him to assume the chief executive leadership role for ACOG since 2011. He then overviews the integral role for ACOG in clinical, economic, and political spheres of the national healthcare environment, and how the voices from this organization can help shape the future of American medicine.
Host: Michael Krychman, MD
The market for sexual health products and accessories, from moisturizers to lubricants to self-stimulators, is very large, and this creates confusion among patients and physicians alike as to which types of products are most helpful for specific sexual health problems. To address ways to gauge the safety and efficacy of sexual health products on the market, particularly for perimenopausal patients with special needs, Dr. Michael Krychman welcomes Dr. Barb Depree, gynecologist, menopause care specialist, and founder of MiddlesexMD, a website providing information and recommended products for women's sexual health.
Host: Michael Krychman, MD
For years, women's sexual health matters have been relatively ignored in both clinical practice and the public eye despite consistently heavy media attention drawn towards men's sexual issues and associated therapeutic products. But there is recent evidence that the tide of public awareness is beginning to change, and that's women's sexual health is becoming more openly discussed across medical, public, and corporate entities. Joining Dr. Michael Krychman to qualify this new trend and examine ways to open communication about sexual health with women in clinical practice is Dr. Alyssa Dweck, assistant clinical professor of OB/GYN at the Mount Sanai School of Medicine and expert in women's sexual health and dysfunction.
Host: Michael Krychman, MD
Bladder leakage is one of many health-related issues that our female patients deal with. There are newly available treatment options, including non-surgical options, to help remedy the problem. Host Dr. Michael Krychman welcomes Dr. Holly Thacker to decipher the pros and cons of the various options available. Dr. Holly L. Thacker, nationally known for her leadership in women’s health, is the founder of the Cleveland Clinic Women’s Health Fellowship and is currently Professor and Director of the Center for Specialized Women’s Health at Cleveland Clinic and Lerner College of Medicine at Case Western Reserve University. She is also author of two books: Women’s Health: Your Body, Your Hormones, Your Choices and Cleveland Clinic Guide to Menopause.
Host: Prathima Setty, MD
Issues of vaginal health are commonly seen in post-menopausal women, breast cancer survivors and women who have had a hysterectomy. According to the US Census Bureau there are nearly 46M women between the ages of 50 and 80, and over 2.8M breast cancer survivors. Existing treatments for post-menopause vaginal health can be time intensive or messy, or contraindicated for health reasons. They also can have numerous side-effects and offer only marginal improvement -- according to a doctor associated with the study.
Host Dr. Prathima Setty welcomes Dr. Mickey Karram, Director of Fellowship Program on Female Pelvic Medicine & Reconstructive Surgery at The Christ Hospital, Cincinnati, OH. Dr. Karram will share preliminary findings from a trail evaluating laser treatment on post-menopausal women and breast cancer survivors experiencing vaginal health issues.
Supported by an Educational Grant from BD Diagnostics.
ReachMD retains full editorial control of the content for this program.
Host: Prathima Setty, MD
What are the benefits and harms of screening women for breast cancer? How often should we screen our patients? Are there technological advancements to help our patients live better and longer? Dr. Prathima Setty welcomes Dr. Russell P. Harris, Professor of Medicine and Adjunct Professor of Epidemiology at University of North Carolina, Chapel Hill, NC.
Supported by an Educational Grant from BD Diagnostics.
ReachMD retains full editorial control of the content for this program.
Host: Lauren Streicher, MD
Guest: Michael Holick, PhD, MD
It seems these days patients know more about the benefits of Vitamin D than their physicians. Doctors are soaking up the information and making sure their patients are taking the proper levels of Vitamin D. Dr. Michael Holick, professor of medicine, physiology and biophysics and director of the Bone Health Care Clinic and the Heliotherapy, Light, and Skin Research Center at Boston University Medical Center, joins host Dr. Lauren Streicher to discuss the proper dosage, risk factors, geographical factors and benefits of Vitamin D.
Guest: Susan Love, MD
Host: Lauren Streicher, MD
Dr. Susan Love, medical director and founder of the Dr. Susan Love Research Foundation, joins host Dr. Lauren Streicher to talk about the Love/Avon Army of Women initiative, which seeks to recruit one million women of all ages and backgrounds to participate in breast cancer research. Dr. Love explains how doctors can apply to be involved in the research process and how your patients can become part of the army of women.
Host: Lauren Streicher, MD
Guest: Jan Shifren, MD
Most research reveals 30 to 40 percent of women in the United States say they have sexual issues. A recent study examined how many women consider their sex issues to be a problem. With host Dr. Lauren Streicher, Dr. Jan Shifren, an associate professor of obstetrics, gynecology and reproductive biology at Harvard Medical School, looks at the findings of her research. The two review the impetus for the study, questions that were asked from 30,000 participants, and what has been gleaned from the results. The two also touch on whether testosterone and Viagra should be prescribed to help women who are distressed by their sexual issues.
Guest: Eugene Lipov, MD
Host: Lauren Streicher, MD
Women who have hot flashes may experience episodes up to 80 times a week. Estrogen is the most common treatment, but oftentimes it's just not enough. Dr. Eugene Lipov, an anesthesiologist and medical director of Northwest Hospital's Advanced Pain Center in Arlington Heights, Illinois, discusses with host Dr. Lauren Streicher his pioneering use of the stellate ganglion block to alleviate hot flashes for women. The two cover the procedure for administering the block, the success rate and complications, as well has how Dr. Lipov came up with the concept. Dr. Lipov also talks about how the block aids in better sleep patterns for post menopausal women.
Guest: Cassing Hammond, MD
Host: Lisa Mazzullo, MD
What's it like to not be able to get a mammogram because the machine does not accommodate a wheelchair? What's it like to be a paraplegic and want to have a baby? These are just two of the growing number of daily problems facing the more than 25 million women with disabilities in the United States. Dr. Cassing Hammond, director of family planning and contraception at the Feinberg School of Medicine at Northwestern University and director of ob/gyn services at the Rehabilitation Institute of Chicago, discusses with host Dr. Lisa Mazzullo the challenge of contraception choices, welcoming these patients to the typical doctor's office, as well as the cutting-edge clinic designed especially for this group of women at the Rehabilitation Institute of Chicago.
Guest: Mishka Terplan, MD
Host: Lisa Mazzullo, MD
Researchers have no way to determine how significant the problem of substance abuse and pregnancy really is. Very few women will be open and honest when it comes to answering questions about elicit drug use. So how do doctors get their patients the proper help? Dr. Mishka Terplan, an associate professor at the University of Chicago, looks at the issues of universal drug screening for all pregnant women, confidentiality, inpatient and outpatient drug rehabilitation programs and the stigma of being a substance abuser, with host Dr. Lisa Mazzullo.
Guest: Marilyn Keefe
Host: Lisa Mazzullo, MD
A new president in the White House will change the climate of reproductive health in this country. Where did we stand under the Bush administration, and how will an Obama administration view access to birth control, emergency contraception, preventive health programs for women and comprehensive sex education programs? Marilyn Keefe, director of reproductive health programs for the National Partnership for Women & Families in Washington, DC, joins host Dr. Lisa Mazzullo to discuss these questions and how the Supreme Court will look at these issues over the next four years.
Guest: Enrique Hernandez, MD
Host: Lisa Mazzullo, MD
Cervical cancer is the second leading cause of death in women around the world. Many of these deaths can be avoided if women with mild cervical dysplasia are treated early. In the last few years, doctors have clarified the cytology and pathology for women in order to treat the problem effectively, while not over-treating the issue. Dr. Enrique Hernandez, chairman of the department of obstetrics, gynecology and reproductive sciences at Temple University School of Medicine in Philadelphia, joins host Dr. Lisa Mazzullo to talk about the treatment plan for women with mild cervical dysplasia as well as recommendations for treating the disease in the future.
Guest: Marianne Legato, MD
Host: Lauren Streicher, MD
Women account for 85 percent of the people in the industrialized world who have reached 100 years of age. What accounts for the longer lifespan of women? Dr. Marianne Legato, founder of the Partnership for Gender-Specific Medicine at Columbia University College of Physicians and Surgeons, talks with host Dr. Lauren Streicher about the significance of gender on life span. They discuss the roles that biology, lifestyle, and social factors play in longevity, and probe whether social changes in the industrialized world may be closing the gap.
Guest: Patrick Lowe, MD
Host: Lauren Streicher, MD
Robotic surgery for gynecology has only been approved by the FDA since 2005. This method is growing popularity among surgeons due to its success rate in treating endometrial cancer and cervical cancer. Dr. Patrick Lowe, director of the Gynecological Robotics and Minimally Invasive Surgery program at Northwestern University Feinberg School of Medicine in Chicago, talks with host Dr. Lauren Streicher about the benefits of robotics and the types of surgery cases that benefit from this cutting edge technology.
Host: Lauren Streicher, MD
Guest: Laura Berman, PhD
How can doctors make their female patients more comfortable talking about sexual dysfunction in the clinical setting? It could be as easy as adding a question to patient intake forms or posting a sign in the waiting room. Host Dr. Lauren Streicher and guest Dr. Laura Berman, an assistant clinical professor of ob/gyn and psychiatry at the Northwestern University Feinberg School of Medicine, talk candidly about female sexual dysfunction issues and treatment options.
Guest: Kim Lebowitz
Host: Lauren Streicher, MD
Women are twice as likely as men to experience depression, and that statistic holds true for female cardiac patients. Linking heart disease and depression, the American Heart Association recently recommended that all cardiac patients be screened for depression. Dr. Kim Lebowitz, director and founder of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital in Chicago, discusses with host Dr. Lauren Streicher the new field of cardiac psychology and how doctors can screen their cardiac patients for the signs and symptoms of depression.
Guest: Lorie Chaiten, JD
Host: Lauren Streicher, MD
For the past 25 years, the U.S. government has funded abstinence-only sex education in public schools. Still, 47 percent of high school students report having had sexual intercourse and 70 percent are sexually active by age 19. Lorie Chaiten, director of the Reproductive Rights Project for the Roger Baldwin Foundation of the ACLU of Illinois, talks with host Dr. Lauren Streicher about the implications for young people's sexual health when they are denied access to complete and accurate science-based information.
Host: Lisa Mazzullo, MD
Guest: Sharmila Makhija, MD
Since the Gardasil vaccination has only been administered to young girls and teens since 2006, there are still questions concerning who should get the vaccine and under what circumstances., and the effectiveness of the vaccine if not taken according to suggested protocol. Dr. Sharmila Makhija, director and associate professor of gynecologic oncology at the University of Alabama, tackles with host Dr. Lisa Mazzullo who should receive the vaccine. They also discuss whether or not it's beneficial for patients to be typed and tested for HPV before receiving the vaccinations, and what happens if a patient becomes pregnant while receiving the vaccine.
Guest: James M Nicholson, MD,MSCE
Host: Lisa Mazzullo, MD
Over the last decade the rate of cesarean sections has increased from 22 percent to as much as 30 percent in some parts of the country. Cesarean risk increases with potential placental insufficiency and concerns about cephalo pelvic disproportion. How does AMOR-IPAT (active management of risk in pregnancy at term), a preventive induction technique, limit cesarean risk? Dr. James M. Nicholson, assistant professor in family practice and community medicine at the University of Pennsylvania School of Medicine, talks with host Dr. Lisa Mazzullo about this technique designed to prevent cesarean deliveries.
Guest: Wendie Berg, MD, PhD
Host: Lisa Mazzullo, MD
The number of women affected by breast cancer every year is staggering: almost 180,000 new cases and upwards of 40,000 deaths. Researchers are focused on finding novel ways to detect a malignancy before it spreads-to the lymph nodes and beyond. Dr. Wendie Berg, a breast imaging radiologist associated with the Johns Hopkins University School of Medicine, talks with host Dr. Lisa Mazzullo about her latest work: studying the use of ultrasound, in conjunction with mammography, to detect breast cancer in high-risk women.
Guest: Elizabeth Kavaler, MD
Host: Lisa Mazzullo, MD
A large number of women suffer from pelvic organ prolapse and incontinence in the United States, many of these women are postmenopausal. Statistics show that one in nine women will undergo surgery for this issue. Dr. Elizabeth Kavaler a urologist at Lenox Hill Hospital in New York joins host Dr. Lisa Mazzullo to discuss the best ways to treat and prevent the issue of pelvic relaxation.
Guest: Elizabeth Kavaler, MD
Host: Lisa Mazzullo, MD
One in 10 American women reports a medically confirmed urinary tract infection (UTI) every year. Combined with the rise of antibiotic resistance in the treatment of cystitis, this has prompted the American College of Obstetrics and Gynecology to amend their guidelines on traditional UTI therapy for women of reproductive age. Dr. Elizabeth Kavaler, urologist at Lenox Hill Hospital in New York City, joins host Dr. Lisa Mazzullo to examine these guidelines, and to share treatment advice for urogenital infections.
Guest: Cynthia Wong, MD
Host: Lisa Mazzullo, MD
Epidural anesthesia has changed dramatically since its introduction to the obstetric arena in the early 1970s. Now we have various types of epidurals we can administer during labor. One of the major obstacles for anesthesiologists is determining how women perceive pain during labor and how to administer the proper dosage of pain medication. Dr. Cynthia Wong, associate professor of anesthesiology at Northwestern University's Feinberg School of Medicine, joins host Dr. Lisa Mazzullo to discuss these issues, and her recent study that looks at the rate of Cesarean deliveries when epidural anesthesia is administered at different times during labor.
Guest: Sharmila Makhija, MD
Host: Lauren Streicher, MD
We are finding the highest prevalence of human papillomavirus (HPV) among women in their early 20s, but the FDA now recommends that an HPV vaccine be administered to women up to the age of 45. Why? Because recent research tells us that the at-risk population may be larger than we think. Dr. Sharmila Makhija, associate professor of gynecologic oncology at Emory University School of Medicine, weighs the pros and cons of this new recommendation with host Dr. Lauren Streicher.
Guest: David Grimes, MD
Host: Lauren Streicher, MD
There are so many choices when it comes to choosing the right contraceptive for your patient that it can make your head spin. Dr. David A Grimes, a clinical professor in the Department of Obstetrics and Gynecology at the University of North Carolina Medical School helps sort out with host Dr. Lauren Streicher the latest options in contraception. They also look at the option of male hormonal contraception and what future birth control methods may soon be available.
Host: Lauren Streicher, MD
Guest: David Grimes, MD
Intrauterine contraception is underutilized in America, compared with usage rates around the globe: despite its documented efficacy, a mere two percent of American women choose this form of birth control. Dr. David A. Grimes, clinical professor of obstetrics and gynecology at the University of North Carolina School of Medicine, reviews the multitude of benefits linked to intrauterine contraception with host Dr. Lauren Streicher. Dr. Grimes also delves into specifics behind the levonorgestrel intrauterine device.
Guest: Abimbola Famuyide, MD
Host: Lisa Mazzullo, MD
For women with severe cardiac disease, pregnancy is not advisable due to significant risks of maternal and fetal morbidity and mortality. Dr. Lisa Mazzullo talks with Dr. Abimbola Famuyide, principle investigator in a recent study on hysteroscopic steriization at the Mayo Clinic in Rochester, Minnesota. Dr. Famuyide's research provides new safer choices for women with heart issues.
Guest: Karen Rosene-Montella, MD
Host: Lisa Mazzullo, MD
The physiological changes that occur in pregnancy often present a series of clinical obstacles. What conditions should most concern us? How can pre-conception education ease the process? Dr. Karen Rosene-Montella, professor of medicine and obstetrics and gynecology at the Warren Alpert Medical School of Brown University, and principal author of Medical Care of the Pregnant Patient, talks with host Dr. Lisa Mazzullo about treating this challenging patient population.
Guest: Stanley Gall, MD
Host: Lisa Mazzullo, MD
Since the 1990s, we have seen a resurgence in infant deaths related to pertussis. Once thought to be a disease of childhood, pertussis attack rates are very high among non-immunized adults. Dr. Stanley Gall, professor of obstetrics and gynecology and women's health at the University of Louisville School of Medicine, analyzes the risk-benefit ratio of immunizing pregnant women and other vulnerable populations with host Dr. Lisa Mazzullo.
Guest: Joseph Flaherty, MD
Host: Lisa Mazzullo, MD
Do the career choices made by female physicians play a central role in the projected shortage of doctors? Host Dr. Lisa Mazzullo explores this provocative idea with Dr. Joseph Flaherty, dean of medicine, and professor of psychiatry and community health sciences at the University of Illinois College of Medicine, taking an in-depth look at the substantive issues that confront many contemporary women in medicine. Beyond gender considerations, does the pursuit of a more balanced life negatively impact the standard of care?
Guest: Maj. Gen. Carla Hawley-Bowland, MD
Host: John Armstrong, MD
Maj. Gen. Dr. Carla Hawley-Bowland, commanding general at Walter Reed Army Medical Center, chief of the United States Army Medical Corps, and the first female Medical Corps General in the history of the United States Army, speaks about the leadership structure that afforded her the opportunity to assume this landmark post. Dr. Hawley-Bowland also touches on women's health issues in the military, and the impending formation of a national military hospital. Dr. John Armstrong hosts.
Guest: Thea Sakata
Host: Lauren Streicher, MD
Guest: Lina Rodriguez
A medical school graduation photo today looks much different than those of the 1950s, with a considerable shift in gender distribution, and a diverse collection of races, nationalities and pre-medical school experiences. Ms. Thea Sakata and Ms. Lina Rodriguez, both first-year medical students at Northwestern University's Feinberg School of Medicine, discuss their unique journeys to medical school with host Dr. Lauren Streicher.
Guest: Veronica Ravnikar, MD
Host: Lauren Streicher, MD
During the 1990's multiple studies suggested hormone replacement therapy would decrease heart disease in women and prolong life. Many doctors encouraged their patients to take estrogen even if they didn't have menopausal symptoms. Dr. Veronica Ravnikar discusses optimizing cardiovascular and cognitive benefits of HRT with the early initiation of therapy.
Guest: Veronica Ravnikar, MD
Host: Lauren Streicher, MD
There is substantial evidence that supports the importance of estrogen to cognitive function, but it seems there is relatively little emphasis on proactively preserving the ability to think clearly once menopause hits. Dr. Veronica Ravnikar, chair of obstetrics and gynecology at South Shore Hospital in Weymouth, Mass., discusses how to treat women with estrogen therapy.
Guest: Sandra Carson, MD
Host: Lauren Streicher, MD
Host Dr. Lauren Streicher continues her discussion with Dr. Sandra Carson, professor of obstetrics and gynecology at the Warren Alpert Medical School at Brown University, on how to tackle the issue of treating obese women. They discuss diet plans, lifestyle modifications, counseling strategies, and medications to best treat obese patients.
Guest: Sandra Carson, MD
Host: Lauren Streicher, MD
Dr. Sandra Carson, professor of obstetrics and gynecology at the Warren Alpert Medical School of Brown University, offers her perspective on the causes and consequences of the obesity epidemic in women. Are there common reasons for weight gain not directly linked to the ratio of food intake versus energy output? How do eating patterns, hormone replacement therapies and other medicines impact weight control? Dr. Lauren Streicher hosts.
Guest: Frank Tu, MD, MPH
Host: Lauren Streicher, MD
Diagnosing chronic pelvic pain can be difficult; managing pelvic pain is sometimes impossible. It's one of the most frustrating problems for the general gynecologist. Dr. Frank Tu of the Division of Gynecological Pain and Minimally Invasive Surgery of Northwestern Healthcare discusses how to treat the patient with chronic pelvic pain.
Guest: Frank Tu, MD, MPH
Host: Lauren Streicher, MD
Surveys suggest that chronic pelvic pain is responsible for 10 percent of all gynecology referrals, 20 percent of all hysterectomies, and 40 percent of all laparoscopies. Frank Tu, MD, MPH, director of gynecological pain and minimally invasive surgery, and assistant professor of obstetrics and gynecology within Northwestern University's Feinberg School of Medicine, joins host Dr. Lauren Streicher to assess the key challenges involved in getting to the root of chronic pelvic pain.
Guest: Anthony Odibo, MD
Host: Lisa Mazzullo, MD
Dr. Anthony Odibo, associate professor of obstetrics and gynecology and director of the Fetal Care Center at Washington University School of Medicine in St. Louis, details the concurrent challenge and promise of perinatal ultrasound, as it applies to first trimester screening and genetic evaluation, preterm labor prediction and minimally invasive fetal therapies. Should our interpretation of the ultrasound change based on our patients' ethnicity or other criteria?
Guest: Mark Hughes, MD, PhD
Host: Lisa Mazzullo, MD
In the context of preimplantation genetic diagnosis (PGD), the revolutionary prospects of the human genome are quite striking. Dr. Mark Hughes, professor of molecular medicine and genetics at Wayne State University School of Medicine, and director of the Genesis Genetics Institute in Detroit, joins host Dr. Lisa Mazzullo to address the inescapable ethical debate surrounding this technology. Further, are there any safety concerns tied to PGD?
Guest: Oliver Schultheiss
Host: Lisa Mazzullo, MD
Dr. Oliver Schultheiss, chair of experimental psychology and neuroscience at Frederich-Alexander University in Erlangen, Germany, discusses his research into the effect of estrogen on the general temperament of women. Dr. Schultheiss tells host Dr. Lisa Mazzullo that estrogen levels may explain specific behavior patterns, including responsiveness to certain motivation styles. Does estrogen also impact affiliation arousal and stress-defined as the ‘hope of closeness' and ‘fear of rejection?'
Guest: Dale Sandler, PhD, MPH
Host: Lisa Mazzullo, MD
Rising rates of breast cancer are of concern to everyone in medicine. To what can we attribute this disturbing trend? For answers, host Dr. Lisa Mazzullo welcomes Dale Sandler, PhD, MPH, chief of epidemiology at the National Institute for Environmental Health Sciences (NIEHS), and principal investigator of the NIEHS Sister Study, a bold initiative to evaluate 50,000 sisters of women with breast cancer, measuring a confluence of environmental factors against their disease risk.
Guest: Nehama Dresner, MD
Host: Lauren Streicher, MD
Many patients who present for specific medical problems suffer from a psychiatric illness for which they are already receiving treatment. Host Dr. Lauren Streicher reviews strategies for effective interfacing of multi-disciplinary care for pregnant or sexually hypoactive women with Dr. Nehama Dresner, associate professor of clinical psychiatry, behavioral sciences, and obstetrics and gynecology at Northwestern University's Feinberg School of Medicine.
Guest: Nehama Dresner, MD
Host: Lauren Streicher, MD
What is the psychological impact on patients faced with difficult obstretic and gynecology-related situations? Dr. Nehama Dresner, associate professor of clinical psychiatry, behavioral sciences, and obstetrics and gynecology at Northwestern University's Feinberg School of Medicine, addresses situational depression and anxiety plaguing these patients with host Dr. Lauren Streicher.
Guest: Nehama Dresner, MD
Host: Lauren Streicher, MD
Postpartum depression and postpartum blues are vastly different clinical concerns, yet the former is often simply viewed (and treated) as a more severe version of the latter. Dr. Nehama Dresner, associate professor of clinical psychiatry, behavioral sciences, and obstetrics and gynecology at Northwestern University Feinberg School of Medicine, joins host Dr. Lauren Streicher to assess the challenges of recognizing and treating postpartum depression.
Guest: Steven Stryker, MD
Host: Lauren Streicher, MD
The prevalence of colorectal cancer could be reduced by 95% with proper screening in every patient at recommended age intervals. That’s according to Dr. Steven Stryker, professor of clinical surgical oncology at Northwestern University’s Feinberg School of Medicine. Yet colorectal cancer remains the second most common cancer in America. Dr. Stryker joins host Dr. Lauren Streicher to explain how physicians can encourage patient compliance with current screening modalities. What circumstances favor virtual screening? Are there other common procedures that can facilitate the diagnosis of colorectal cancer?
Guest: Steven Stryker, MD
Host: Lauren Streicher, MD
There is a dramatically uneven distribution of risk among women for colorectal cancer, the second most common cancer in America. Low-risk women have only five percent lifetime odds of developing the disease, while moderate and high-risk subsets are much more vulnerable. What accounts for this risk? The evidence points to a series of genetic and environmental factors, along with other known syndromes. Dr. Steven Stryker, professor of clinical oncology at Northwestern University’s Feinberg School of Medicine, joins host Dr. Lauren Streicher to evaluate common predispositions to this devastating disease.
Guest: Bruce McLucas, MD
Host: Lauren Streicher, MD
It’s generally accepted as appropriate and efficacious treatment for symptomatic uterine fibroids, but uterine artery embolization is dogged by questions about its short- and long-term outcomes. Host Dr. Lauren Streicher addresses the debate with Dr. Bruce McLucas, clinical assistant professor in the department of obstetrics and gynecology at the UCLA David Geffen School of Medicine. How should we approach this dialogue with our patients?
Guest: Bruce McLucas, MD
Host: Lauren Streicher, MD
Despite 600,000 hysterectomies, fibroids remain the number one reason women undergo surgery. While removal of the uterus may be the best treatment, uterine artery embolization may be a non-surgical option for many women with symptomatic fibroids. Dr. Lauren Streicher speaks with Dr. Bruce McLucas, clinical assistant professor in the department of obstetrics and gynecology at the UCLA David Geffen School of Medicine, to discuss candidate evaluation for a successful uterine artery fibroid embolization, and the efficacy of gynecologists who are performing the procedure.
Guest: Lee Philip Shulman, MD, FACOG, FACMG
Host: Lisa Mazzullo, MD
Few would quibble with the notion that every patient, irrespective of age, needs genetic screening. When it comes to prenatal testing, early answers are ideal for expectant mothers and their families. Dr. Lee Shulman, professor and chair of reproductive genetics at Northwestern University Feinberg School of Medicine, examines AFP-serum markers, triple and quad screens, and the increasing accuracy we’re now seeing among first trimester non-invasive testing.
Guest: Lee Philip Shulman, MD, FACOG, FACMG
Host: Lisa Mazzullo, MD
Prenatal screening and diagnosis are often used interchangeably, confusing both patients and physicians on the actual meaning of these two very different genetic testing options. This uncertainty has caused a growing concern in pregnant patients and a desire for greater clarity in their genetic screening options. Join host Dr. Lisa Mazzullo, assistant professor of OB-GYN at Northwestern University's Feinberg School of Medicine and her guest, Director of the Reproductive Genetics Department and Distinguished Physician at Northwestern Memorial Hospital, Lee Shulman, MD, as they review the difference between screening and diagnosis in addition to discussing the newest and most accurate forms of prenatal genetic testing options.
Guest: Michael Koren, MD
Host: Lauren Streicher, MD
If you had instant access to the opinion of a panel of board-certified physicians, would this augment your approach to the practice of medicine? Ask 100 Doctors is an organization providing web-based consultation technology, which strives to connect physicians from all corners of medicine. Dr. Michael Koren, founder of Ask 100 Doctors, joins host Dr. Lauren Streicher to examine the utility of this service.
Host: Lauren Streicher, MD
Guest: Marla Mendelson, MD
Marfan Syndrome, an inherited connective tissue disorder, affects 1 in 10,000 to 1 in 20,000 individuals. Women with Marfan Syndrome have a wide range of abnormalities involving the lungs, skin, ocular, musculoskeletal and cardiovascular systems. Today we are joined by Dr. Marla A. Mendelson, an assistant professor of Medicine at Northwestern University’s Feinberg School of Medicine, and director of the Women’s Cardiology program of the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital which has just opened a clinic devoted to the management of women with Marfan syndrome.
Guest: Marla Mendelson, MD
Host: Lauren Streicher, MD
According to the National Center for Health Statistics one in nine women will develop some form of cardiovascular disease by age 64. After age 65, the ratio rises to one in three women. Few women however, know what they should be doing to prevent heart disease, even though it is ten times more likely that an American woman will die from heart disease than from breast cancer.
Guest: Marla Mendelson, MD
Host: Lauren Streicher, MD
It is 10 times more likely that an American woman will die of cardiovascular disease than breast cancer. Yet few female patients know what they should be doing to prevent heart disease. How can we help? Dr. Marla Mendelson, director of the women’s cardiology program and assistant professor of medicine at Northwestern University Feinberg School of Medicine, reviews gender-specific cardiovascular risk factors and screening mechanisms with host Dr. Lauren Streicher.
Guest: Jan Berger, MD
Host: Lauren Streicher, MD
An array of tools on the internet, coupled with direct-to-consumer marketing by pharmaceutical companies, have put us in a situation where patients obtain much of their medical knowledge from sources other than their personal physician. Dr. Jan Berger, senior vice president and chief clinical officer of CVS Caremark Corporation, outlines effective communication strategies that will help you ensure that your patients are receiving accurate medical information. Dr. Lauren Streicher hosts.
Guest: Jan Berger, MD
Host: Lauren Streicher, MD
Up to 50% of the prescriptions we write are never filled. Even when the patient does initiate recommended treatment, roughly half discontinue that treatment without informing or consulting their physicians. Medication management is one area that is showing increasing risk for medical liability as well as significant time and cost to the healthcare environment. Dr. Jan Berger discusses reducing liabilty.
Guest: Brian Kaplan, MD
Host: Lauren Streicher, MD
Prenatal diagnosis of genetic disorders has traditionally involved testing of an established pregnancy by utilizing chorionic villus sampling or amniocentesis. In the event that an abnormality is detected, pregnancy termination is then offered as an option. Pre-implantation Genetic Diagnosis (PGD) is an option that can be utilized during In Vitro Fertilization to avoid the transfer of abnormal embryos. PGD may have the additional value of improving pregnancy rates when undergoing assisted reproductive technologies. Dr. Kaplan discusses thestate of the art of PGD including current and future applications.
Guest: Brian Kaplan, MD
Host: Lauren Streicher, MD
While freezing embryos has long been an option, many single women who hope to have a future partner, are requesting oocyte preservation rather than utilizing donor sperm. Dr. Kaplan discusses new methods of cryopreservation , current clinical recommendations and outcomes.
Guest: Ted Anderson, MD, PhD
Host: Lauren Streicher, MD
What are the most important considerations for our female patients as potential candidates for endometrial ablation? Dr. Ted Anderson, associate professor of obstetrics and gynecology at Vanderbilt University School of Medicine, outlines the preoperative evaluation process with host Dr. Lauren Streicher, including a review of five devices which are FDA approved for the procedure.
Guest: Ted Anderson, MD, PhD
Host: Lauren Streicher, MD
Dr. Ted Anderson, Associate Professor of Obstetrics and Gynecology at Vanderbilt University Medical Center, discusses revised ACOG guidelines, pre-operative evaluation, and choosing appropriate patients for Endometrial Ablation. Dr. Anderson also discuses the potential pitfalls of Endometrial Ablation
Guest: Joyce Walsleben, RN, PhD
Host: Lisa Mazzullo, MD
57% of women are affected by a sleep disturbance in their lifetime. How often are their complaints insomnia versus obstructive sleep apnea? Once thought to affect obese men primarily, extensive research in the area of OSA in women by Dr. Joyce Walsleben has revealed treatment modalities you can employ to help your patients.
Guest: Cathy Wicklund, MS
Host: Lisa Mazzullo, MD
The Genetic Counselor as an amazing tool in your medical armamentarium: As the genome becomes better understood new medical challenges will become evident. The tools to best educate ourselves and to assist our patients as they need to determine the w’s: when, who and why should someone undergo genetic testing. The what do I do after I know I have a genetic predisposition to a disease is an entire challenge on to itself that we must as health care providers help guide our patients . A team approach made up of genetic counselors, medical staff and possibly psychological staff will offer the most comprehensive care when genetic issues arise. Cathy Wicklund helps us understand the role of the genetic counselor and the ways they can help our patients with regards to genetic health testing.
Guest: Joanna Rudnick
Host: Lisa Mazzullo, MD
Guest: Julie Burger, JD
Genetic Discrimination- There should be a law against it, and we’re working on it; The Genetic Information Non Discrimination Act (GINA). What is the ethical and legal dilemma of BRCA 1 / 2 testing? 30,000 women have tested positive for brca1 or 2 but an estimated 250,000 women are suspected to be positive as well but are afraid to be tested due to possible genetic discrimination. The reality of health insurance, disability and employment discrimination due to genetic testing is daunting and is preventing women from taking action against the possible cancer diagnosis in their future. Julie Burger shares with us the legal dilemma and frustrations of genetic information discrimination. Additional References: Coalition For Genetic Fairness: www.geneticfairness.org Halsey Lea, d, et al Ethical Issues in Genetic Testing, J Midwifery Womens Health, 2005; 50 (3); 234-40. - Genomics and personalized Medicine act, 2006, Obama http://en.wikipedia.org/wiki/genetic_information_nondiscrimination_act - www.genome.gov/24519851- discusses the nuances of the gina act.
Guest: Joanna Rudnick
Host: Lisa Mazzullo, MD
From a medical, ethical and psychological perspective, Joanna Rudnick has faced heart-wrenching choices about childbearing, life-altering surgeries, preventive lifestyle changes, and much more. Young women like Ms. Rudnick, who possesses BRCA gene mutations, look to their healthcare providers for guidance through this harrowing journey. How can we help? She talks with host Dr. Lisa Mazzullo about the difficult decisions of genetic testing, and the challenges of treating for disease based on genetic projections.
Guest: Joyce Walsleben, RN, PhD
Host: Lisa Mazzullo, MD
Complaints of sleep disturbances are much more common in women than in men. In this segment we explore the etiology of insomnia that contributes to the greater prevalence of insomnia in women, especially in their postmenopausal years. Treatment modalities, alternatives to medications and tidbits on how to improve your patient’s quality of sleep is all discussed with Dr. Walsleben- a dedicated physician who has researched and cared for patients who suffer from sleep disturbances for over 20 years.
Guest: Alan Peaceman, MD
Host: Lisa Mazzullo, MD
Cesarean section on maternal request is becoming a more common discussion in doctors offices around the country. Since the late 90’s, cesarean section rates continue to rise with overall estimates of 29% noted in 2004. The ethics of patient autonomy war with medical concerns about potentially unnecessary surgery. The challenges posed by elective cesarean section are discussed with Dr. Alan Peaceman, professor of ob/gyn at Northwestern University Feinberg School of Medicine and chief of the division of MFM. Neonatal and maternal safety, long term sequelae of vaginal birth and NIH recommendations on how to deal with this potentially emotional issue are thoroughly discussed. Reference Articles 1. Declercq, E, PhD, et al. Factors associated with the rise in Primary Cesarean Births in the US in 2002, Am J Public Health, 2006; 96(5): 867-872 2. National Institute of Health- Cesarean Childbirth. UDHHS- 2006, , 1982-2067 3. Greene, M. et al. Vaginal Delivery after Cesarean section – is the risk acceptable? N Engl J Med 2001, 345:55-56 4. Andrist, Linda, PhD, RNC. NPWH 2006- Cesarean Section on Maternal Request_ the debate.
Guest: Alan Peaceman, MD
Host: Lisa Mazzullo, MD
Preterm labor and delivery has an enormous impact on medical society and society in general. In fact, 12% of all deliveries in the United States occur before 37 weeks gestation, which makes preterm delivery the greatest contributor to neonatal morbidity and mortality. Dr. Alan Peaceman, Professor of Obstetrics and Gynecology at Northwestern University’s Feinberg School of Medicine and chief of the MFM division, joins us to discuss the challenges of predicting and preventing preterm birth. Explore with us the new trends in medical therapy that can help significantly reduce the incidence of preterm birth with progesterone. The limitations and promise of biochemical markers, such as fetal fibronectin, and clinical predictors, such as ultrasound measured cervical length for subsequent preterm birth are also reviewed. Progesterone Protocol Information about the use of progesterone therapy can be found on the ACOG website, October 31, 2003 Reference Articles: 1. Peaceman, AM, et al. Fetal fibronectin as a predictor of preterm patients with symptoms; a multicenter trial. Am Journal of Ob/Gyn 1997;177:13-18 2. Adams, Melissa, et al. Rates of and factors associated with recurrence of preterm delivery, JAMA, 2000;283:1591 Articles of interest on the topic of preterm labor management include: 1. Wapner, Ronald, et al. …
Guest: Sam Thatcher, MD, PhD
Host: Lisa Mazzullo, MD
Anovulation is a significant challenge for reproductive age women. The most common endocrinologic cause of this is PCOS. With the help of Dr. Sam Thatcher, pioneer in IVF technology and director of the Center for Applied Reproductive Science, we explore the exciting new possibilities and not-so-new controversies that exist with regard to treatment for PCOS patients. Helpful information about the medical therapies available for patients with PCOS such as clomid, metformin and oral contraceptives are presented. He also disputes the ‘one size fits all” theory when it comes to the care of women with PCOS. Reference material: 1. Legro, RS et al. Clomiphene, metformin or both for fertility in PCOS. N Engl J Med 2007; 356:551-56
Guest: Sam Thatcher, MD, PhD
Host: Lisa Mazzullo, MD
Polycystic ovary syndrome (PCOS) imperils reproductive age women, posing pressing concerns about fertility, and increasing risk of diabetes, heart disease, and endometrial cancer. Dr. Sam Thatcher, director of the multi-site Center for Applied Reproductive Science, considers the mechanisms of PCOS inheritance, essential diagnostic criteria, and the subsequent challenges of managing this disorder.
Guest: Murray Favus, MD
Host: Lauren Streicher, MD
Dr. Murray Favus, a Professor of Medicine at The University of Chicago Pritzker School of Medicine, and director of The University of Chicago Bone Program discusses denosumab, zoledronic acid, oral calcium sensing receptor antagonists, and other emerging therapies for osteoporosis.
Guest: Murray Favus, MD
Host: Lauren Streicher, MD
Dr. Lauren Streicher speaks with Dr. Murray Favus, professor of medicine at the University of Chicago Pritzker School of Medicine and director of the University of Chicago Bone Disease Program, about managing patients who are not tolerating a bisphosphonate or who do not respond to bisphosphonate therapy.
Guest: Murray Favus, MD
Host: Lauren Streicher, MD
Dr. Lauren Striecher speaks to Dr. Murray Favus, a Professor of Medicine at The University of Chicago Pritzker School of Medicine, and director of The University of Chicago Bone Program. They will discuss management of patients identified with osteoporosis.
Guest: Rachel Brem, MD
Host: Lauren Streicher, MD
Dr. Rachel Brem, the Director of mammaography at George Washington University Medical Center, discusses the role of digital mammography, plain film mammography, utlrasound, and MRI for primary screening of breast cancer.
Guest: Rachel Brem, MD
Host: Lauren Streicher, MD
Dr. Rachel Brem, director of mammaography at George Washington University Medical Center, discusses her recent work published in The Breast Journal regarding the role of breast- specific gamma imaging for women with equivocal mammographic findings.
Guest: Richard Baer, MD
Host: Lauren Streicher, MD
Psychiatrist Richard Baer, MD, author of Switching Time, discusses the impact of childhood sexual abuse on the development of adult psychiatric illness.
Guest: Richard Baer, MD
Host: Lauren Streicher, MD
Vast challenges present themselves in the diagnosis and treatment of multiple personality disorder. Dr. Richard Baer, the former president of the Illinois Psychiatric Society, discusses a particular case - involving one patient and her 17 different personalities - as the subject of his book, "Switching Time".
Guest: Arthur Klatsky, MD
Host: Lisa Mazzullo, MD
Join Dr. Klatsky while he discusses the new findings on the relevance of Alcohol type as it relates to Breast Cancer.
Guest: Diljeet Singh, MD
Host: Lisa Mazzullo, MD
Dr. Mazzullo and Dr. Singh discuss the genetic detection of ovarian cancer and the challenges it proposes.
Guest: Diljeet Singh, MD
Host: Lisa Mazzullo, MD
Ovarian Cancer affects 1 in 70 women over their lifetimes. It is the #2 most common gynecological malignancy, yet 95% of women experience symptoms in the months before they receive diagnosis. What can we do to increase early detection of Ovarian Cancer?
Guest: Clarisa Gracia, MD
Host: Lisa Mazzullo, MD
More than five percent of new cancer cases occur in women of prepubescent and childbearing age. Which of the current cancer treatments specifically influence fertility? Are prepubescent women less vulnerable to the damaging effects of therapy? Dr. Clarisa Gracia, assistant professor of obstetrics and gynecology at the University of Pennsylvania School of Medicine, joins host Dr. Lisa Mazzullo to review methods to reduce and monitor the impact of chemotherapy or radiation on fertility.
Guest: Clarisa Gracia, MD
Host: Lisa Mazzullo, MD
Dr. Gracia and Dr. Mazzullo discuss ovarian function and fertility before, during and after cancer treatments. The new ways in which we are beginning to perserve fertility provides hope for young cancer patients.
Guest: Clarisa Gracia, MD
Host: Lisa Mazzullo, MD
There are over 10 million new cancer diagnoses every year, and 5% occur in women of pre-pubescent and child-bearing ages. What impact does this have on their fertility, and what new measures are being taken before patients undergo treatment to protect the future of their fertility? Dr. Clarisa Gracia, assistant professor of obstetrics and gynecology at the University of Pennsylvania School of Medicine, joins host Dr. Lisa Mazzullo.